Last reviewed · How we verify

NCT04969640

Role of Anterior Segment Optical Coherence Tomography in Infectious Keratitis

Completed Last updated 29 March 2023
What this trial tests

trial testing Optical coherence tomography in Infective Keratitis in 23 participants. Completed in 31 December 2021.

Timeline
1 July 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorMinia University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment23
Start date1 July 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Eligibility, any sex, with Infective Keratitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the role of anterior segment optical coherence tomography in follow up of infectious keratitis and assessment of response to treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Optical coherence tomography

Trials testing the same drug.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing